Deregulation of the Mitochondrial Apoptotic Machinery and Development of Molecular Targeted Drugs in Acute Myeloid Leukemia

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|8|3|207-222

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.8, Iss.3, 2008-05, pp. : 207-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of personalized molecular therapy for acute myeloid leukemia

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 1, 2016-01 ,pp. : 20-29

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Drugs in Chronic Myeloid Leukemia

By  

Current Medicinal Chemistry, Vol. 15, Iss. 29, 2008-12 ,pp. : 3036-3051

Bentham Science Publishers

Access to resources Recommend Favorite

Novel and Emerging Drugs for Acute Myeloid Leukemia

By  

Current Cancer Drug Targets, Vol. 12, Iss. 5, 2012-05 ,pp. : 522-530

Bentham Science Publishers

Access to resources Recommend Favorite

Xenograft models of primary acute myeloid leukemia for the development of imaging strategies and evaluation of novel targeted therapies.

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 1, 2016-01 ,pp. : 42-51

Bentham Science Publishers

Access to resources Recommend Favorite

Molecularly Targeted Therapies for Pediatric Acute Myeloid Leukemia: Progress to Date

By Brown Patrick   Smith Franklin O.  

Pediatric Drugs, Vol. 10, Iss. 2, 2008-01 ,pp. : 85-92

Adis International

Access to resources Recommend Favorite